Literature DB >> 25370284

Schizophrenia and depression.

Peter Bosanac1, David J Castle2.   

Abstract

Depressive symptoms are common in people with schizophrenia and can be associated with suicidality, but are often either missed or dismissed by clinicians. General practitioners have a key role in initial assessment and subsequent monitoring of depressive symptoms, associated risks and physical health in patients with schizophrenia. Liaison with appropriate non-government organisations and public or private specialist mental health services can enhance GPs' management of depression in schizophrenia. Antidepressants, prescribed in tandem with antipsychotics, have a likely therapeutic role for persistent depressive symptoms in schizophrenia, but side effects can be troublesome. Although some of the atypical antipsychotics appear to have primary antidepressant effects, the utility of these agents alone in the setting of persistent depressive symptoms in schizophrenia has not been established.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 25370284     DOI: 10.5694/mja12.10516

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

1.  Comorbid Diabetes and Depression in a National Sample of Adults With Psychosis.

Authors:  Debra L Foley; Andrew Mackinnon; Vera A Morgan; David J Castle; Anna Waterreus; Cherrie A Galletly
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

Review 2.  Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Meenakshi Dauwan; Marieke J H Begemann; Sophie M Heringa; Iris E Sommer
Journal:  Schizophr Bull       Date:  2015-11-07       Impact factor: 9.306

3.  Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder.

Authors:  Julia Ermel; Cameron S Carter; James M Gold; Angus W MacDonald; J Daniel Ragland; Steven M Silverstein; Milton E Strauss; Deanna M Barch
Journal:  Schizophr Res Cogn       Date:  2017-05-09

4.  Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia.

Authors:  S H Witt; F Streit; M Jungkunz; J Frank; S Awasthi; C S Reinbold; J Treutlein; F Degenhardt; A J Forstner; S Heilmann-Heimbach; L Dietl; C E Schwarze; D Schendel; J Strohmaier; A Abdellaoui; R Adolfsson; T M Air; H Akil; M Alda; N Alliey-Rodriguez; O A Andreassen; G Babadjanova; N J Bass; M Bauer; B T Baune; F Bellivier; S Bergen; A Bethell; J M Biernacka; D H R Blackwood; M P Boks; D I Boomsma; A D Børglum; M Borrmann-Hassenbach; P Brennan; M Budde; H N Buttenschøn; E M Byrne; P Cervantes; T-K Clarke; N Craddock; C Cruceanu; D Curtis; P M Czerski; U Dannlowski; T Davis; E J C de Geus; A Di Florio; S Djurovic; E Domenici; H J Edenberg; B Etain; S B Fischer; L Forty; C Fraser; M A Frye; J M Fullerton; K Gade; E S Gershon; I Giegling; S D Gordon; K Gordon-Smith; H J Grabe; E K Green; T A Greenwood; M Grigoroiu-Serbanescu; J Guzman-Parra; L S Hall; M Hamshere; J Hauser; M Hautzinger; U Heilbronner; S Herms; S Hitturlingappa; P Hoffmann; P Holmans; J-J Hottenga; S Jamain; I Jones; L A Jones; A Juréus; R S Kahn; J Kammerer-Ciernioch; G Kirov; S Kittel-Schneider; S Kloiber; S V Knott; M Kogevinas; M Landén; M Leber; M Leboyer; Q S Li; J Lissowska; S Lucae; N G Martin; F Mayoral-Cleries; S L McElroy; A M McIntosh; J D McKay; A McQuillin; S E Medland; C M Middeldorp; Y Milaneschi; P B Mitchell; G W Montgomery; G Morken; O Mors; T W Mühleisen; B Müller-Myhsok; R M Myers; C M Nievergelt; J I Nurnberger; M C O'Donovan; L M O Loohuis; R Ophoff; L Oruc; M J Owen; S A Paciga; B W J H Penninx; A Perry; A Pfennig; J B Potash; M Preisig; A Reif; F Rivas; G A Rouleau; P R Schofield; T G Schulze; M Schwarz; L Scott; G C B Sinnamon; E A Stahl; J Strauss; G Turecki; S Van der Auwera; H Vedder; J B Vincent; G Willemsen; C C Witt; N R Wray; H S Xi; A Tadic; N Dahmen; B H Schott; S Cichon; M M Nöthen; S Ripke; A Mobascher; D Rujescu; K Lieb; S Roepke; C Schmahl; M Bohus; M Rietschel
Journal:  Transl Psychiatry       Date:  2017-06-20       Impact factor: 6.222

5.  Mediating Effect of Hope on the Relationship Between Depression and Recovery in Persons With Schizophrenia.

Authors:  Sri Padma Sari; Murti Agustin; Diyan Yuli Wijayanti; Widodo Sarjana; Umi Afrikhah; Kwisoon Choe
Journal:  Front Psychiatry       Date:  2021-02-09       Impact factor: 4.157

6.  Dynamic contextual influences on social motivation and behavior in schizophrenia: a case-control network analysis.

Authors:  Varsha D Badal; Emma M Parrish; Jason L Holden; Colin A Depp; Eric Granholm
Journal:  NPJ Schizophr       Date:  2021-12-09

Review 7.  Depression and Schizophrenia: Cause, Consequence, or Trans-diagnostic Issue?

Authors:  Rachel Upthegrove; Steven Marwaha; Max Birchwood
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

8.  Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study.

Authors:  Valentina Corigliano; Anna Comparelli; Iginia Mancinelli; Benedetta Montalbani; Dorian A Lamis; Antonella De Carolis; Denise Erbuto; Paolo Girardi; Maurizio Pompili
Journal:  Schizophr Res Treatment       Date:  2018-08-30

9.  Depression among Patients with Schizophrenia in Ethiopian Mental Health Hospital: Association with Sociodemographic and Clinical Variables: A Cross-Sectional Study.

Authors:  Mandaras Tariku; Tilahun Ali; Tadesse Misgana; Mohammedamin Hajure; Henock Asfaw
Journal:  Depress Res Treat       Date:  2021-02-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.